title: Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy.
abstract: Scopolamine (1.5 mg/kg; i.p.) or amphetamine (3 mg/kg; i.p.) increases locomotion and stereotyped behavior patterns in rats. Previous studies suggest that scopolamine acts via muscarinic receptors near the midbrain-pons border. In this study, unilateral microinjections in N-methyl-scopolamine (2.5-10 microg) into the laterodorsal tegmental nucleus (LDT) increased locomotion. Bilateral ibotenate lesions of the LDT attenuated scopolamine-induced locomotion by 68% 7 days postlesion, and by 35% 28 days postlesion. LDT lesions reduced scopolamine-induced stereotypy less than locomotion. The sensitization to amphetamine observed on repeated tests was attenuated by LDT lesions for stereotypy, but not for locomotion. These findings suggest that scopolamine induces locomotion largely, but not exclusively, by blocking muscarinic receptors in LDT.
authors.affiliation: Department of Psychology, University of Toronto, Ontario, Canada.
authors.forename: S R
authors.initials: SR
authors.lastname: Laviolette
authors.forename: R P
authors.initials: RP
authors.lastname: Priebe
authors.forename: J S
authors.initials: JS
authors.lastname: Yeomans
mesh_terms: D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D019832:N-Methylscopolamine / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013239:Stereotyped Behavior / Q000187:drug effects*; D013681:Tegmentum Mesencephali / Q000502:physiology*
chemical_list: D018727:Muscarinic Antagonists; D000661:Amphetamine; D019832:N-Methylscopolamine